Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
84.12
+0.91 (1.09%)
At close: Aug 29, 2025, 4:00 PM
84.13
+0.01 (0.02%)
After-hours: Aug 29, 2025, 7:56 PM EDT

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of $210.11 billion. The enterprise value is $236.89 billion.

Market Cap210.11B
Enterprise Value 236.89B

Important Dates

The next estimated earnings date is Thursday, October 30, 2025, before market open.

Earnings Date Oct 30, 2025
Ex-Dividend Date Sep 15, 2025

Share Statistics

Merck & Co. has 2.50 billion shares outstanding. The number of shares has decreased by -0.77% in one year.

Current Share Class 2.50B
Shares Outstanding 2.50B
Shares Change (YoY) -0.77%
Shares Change (QoQ) -0.71%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 79.98%
Float 2.49B

Valuation Ratios

The trailing PE ratio is 12.97 and the forward PE ratio is 9.18. Merck & Co.'s PEG ratio is 0.97.

PE Ratio 12.97
Forward PE 9.18
PS Ratio 3.34
Forward PS 3.17
PB Ratio 4.30
P/TBV Ratio 17.21
P/FCF Ratio 14.27
P/OCF Ratio 11.34
PEG Ratio 0.97
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.36, with an EV/FCF ratio of 16.09.

EV / Earnings 14.44
EV / Sales 3.72
EV / EBITDA 8.36
EV / EBIT 9.89
EV / FCF 16.09

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio 1.42
Quick Ratio 0.82
Debt / Equity 0.72
Debt / EBITDA 1.23
Debt / FCF 2.40
Interest Coverage 18.77

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.04%.

Return on Equity (ROE) 35.42%
Return on Assets (ROA) 13.01%
Return on Invested Capital (ROIC) 18.04%
Return on Capital Employed (ROCE) 26.18%
Revenue Per Employee $848,213
Profits Per Employee $218,747
Employee Count75,000
Asset Turnover 0.55
Inventory Turnover 2.20

Taxes

In the past 12 months, Merck & Co. has paid $2.74 billion in taxes.

Income Tax 2.74B
Effective Tax Rate 14.32%

Stock Price Statistics

The stock price has decreased by -28.35% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -28.35%
50-Day Moving Average 82.07
200-Day Moving Average 87.89
Relative Strength Index (RSI) 53.68
Average Volume (20 Days) 10,933,935

Short Selling Information

The latest short interest is 25.53 million, so 1.02% of the outstanding shares have been sold short.

Short Interest 25.53M
Short Previous Month 28.77M
Short % of Shares Out 1.02%
Short % of Float 1.02%
Short Ratio (days to cover) 2.17

Income Statement

In the last 12 months, Merck & Co. had revenue of $63.62 billion and earned $16.41 billion in profits. Earnings per share was $6.49.

Revenue63.62B
Gross Profit 49.25B
Operating Income 23.95B
Pretax Income n/a
Net Income 16.41B
EBITDA 28.33B
EBIT 23.95B
Earnings Per Share (EPS) $6.49
Full Income Statement

Balance Sheet

The company has $8.62 billion in cash and $35.40 billion in debt, giving a net cash position of -$26.78 billion or -$10.72 per share.

Cash & Cash Equivalents 8.62B
Total Debt 35.40B
Net Cash -26.78B
Net Cash Per Share -$10.72
Equity (Book Value) 49.06B
Book Value Per Share 19.57
Working Capital 11.03B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $18.53 billion and capital expenditures -$3.81 billion, giving a free cash flow of $14.72 billion.

Operating Cash Flow 18.53B
Capital Expenditures -3.81B
Free Cash Flow 14.72B
FCF Per Share $5.89
Full Cash Flow Statement

Margins

Gross margin is 77.41%, with operating and profit margins of 37.64% and 25.79%.

Gross Margin 77.41%
Operating Margin 37.64%
Pretax Margin 30.12%
Profit Margin 25.79%
EBITDA Margin 44.53%
EBIT Margin 37.64%
FCF Margin 23.14%

Dividends & Yields

This stock pays an annual dividend of $3.24, which amounts to a dividend yield of 3.85%.

Dividend Per Share $3.24
Dividend Yield 3.85%
Dividend Growth (YoY) 5.19%
Years of Dividend Growth 14
Payout Ratio 49.96%
Buyback Yield 0.77%
Shareholder Yield 4.62%
Earnings Yield 7.81%
FCF Yield 7.01%
Dividend Details

Analyst Forecast

The average price target for Merck & Co. is $108.54, which is 29.03% higher than the current price. The consensus rating is "Buy".

Price Target $108.54
Price Target Difference 29.03%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (5Y) 2.01%
EPS Growth Forecast (5Y) 8.05%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Feb 17, 1999
Split Type Forward
Split Ratio 2:1

Scores

Merck & Co. has an Altman Z-Score of 4.33 and a Piotroski F-Score of 6.

Altman Z-Score 4.33
Piotroski F-Score 6